Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2013-07-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Trial to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
NCT05428761
Efficacy of Different Oral Rehydration Solutions on the Hydration Status of Healthy Males
NCT05428774
The Efficacy of Oral Versus Intravenous Hypertonic Saline Administration in Runners With Exercise-Associated Hyponatremia
NCT01110655
Oral Rehydration Solution in Healthy Adults
NCT06130475
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
NCT05428228
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Water with flavoring and non-nutritive sweetener.
Water with flavoring and non-nutritive sweetener.
A volume of fluid (water) was given after exercise to return each subject's body mass (to euhydration).
High-Na low-CHO beverage
Beverage containing sodium concentration of 40 to 50 mEq/L and carbohydrate concentration between 310 and 350 mmol/L.
High-Na low-CHO beverage
A volume of fluid (high-Na, low-CHO) was given after exercise to return each subject's body mass (to euhydration).
Low-Na high-CHO beverage
Beverage containing sodium concentration of 15 to 25 mEq/L and carbohydrate concentration between 120 and 160 mmol/L.
Low-Na high-CHO beverage
A volume of fluid (low-Na, high-CHO) was given after exercise to return each subject's body mass (to euhydration).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Water with flavoring and non-nutritive sweetener.
A volume of fluid (water) was given after exercise to return each subject's body mass (to euhydration).
High-Na low-CHO beverage
A volume of fluid (high-Na, low-CHO) was given after exercise to return each subject's body mass (to euhydration).
Low-Na high-CHO beverage
A volume of fluid (low-Na, high-CHO) was given after exercise to return each subject's body mass (to euhydration).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
University of Illinois at Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Craig A. Horswill
Clinical Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Craig Horswill, PhD
Role: PRINCIPAL_INVESTIGATOR
UIC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Illinois
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AN-US-1307
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.